Melatonin induces mitochondrial-mediated apoptosis in human myeloid HL-60 cells

Ignacio Bejarano1, Pedro C Redondo, Javier Espino

  • 1Department of Physiology, University of Extremadura, Badajoz, Spain.

Insights

Melatonin, a hormone, can trigger apoptosis (programmed cell death) in human leukemia cells (HL-60). This study shows melatonin activates key caspases and proapoptotic proteins, suggesting oncostatic effects.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Melatonin's role in apoptosis is complex, showing antiapoptotic effects in normal cells but potentially proapoptotic effects in certain tumor cells.
  • Understanding melatonin's impact on cancer cell death is crucial for exploring therapeutic strategies.

Purpose of the Study:

  • To investigate the effect of melatonin on apoptosis in the human leukemia cell line HL-60.
  • To elucidate the molecular mechanisms underlying melatonin-induced apoptosis in these cells.

Main Methods:

  • HL-60 cells were treated with melatonin (1 mM).
  • Assays were performed to measure caspase-3 and -9 activities, mitochondrial membrane potential, and cell death.
  • Expression and association of proapoptotic proteins Bax and Bid were analyzed.

Main Results:

  • Melatonin significantly increased caspase-3 and -9 activities in a time-dependent manner.
  • Mitochondrial membrane depolarization and permeability transition pore induction were observed.
  • Melatonin treatment led to increased cell death (apoptosis/necrosis) and elevated levels/association of Bax and Bid proteins.

Conclusions:

  • Melatonin exhibits proapoptotic effects in the human myeloid leukemia cell line HL-60.
  • The findings suggest potential oncostatic roles for melatonin in this leukemia model.
  • Melatonin induces apoptosis via caspase activation, mitochondrial dysfunction, and modulation of Bax/Bid pathways.